These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT). Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536 [TBL] [Abstract][Full Text] [Related]
8. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive. Brumbaugh DE; De Zoeten EF; Pyo-Twist A; Fidanza S; Hughes S; Dolan SA; Child J; Dominguez SR J Pediatr; 2018 Mar; 194():123-127.e1. PubMed ID: 29198534 [TBL] [Abstract][Full Text] [Related]
9. Successful Fecal Microbiota Transplantation as an Initial Therapy for Clostridium difficile Infection on an Outpatient Basis. Tanaka T; Kato H; Fujimoto T Intern Med; 2016; 55(8):999-1000. PubMed ID: 27086820 [TBL] [Abstract][Full Text] [Related]
10. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694 [TBL] [Abstract][Full Text] [Related]
11. [Fecal microbiota transplantation through colonoscopy for Clostridium difficile recurrent infection. Report of eight cases]. Quera R; Ibáñez P; Simian D; Rivera D; Acuña G; Espinoza R Rev Med Chil; 2018 Aug; 146(8):823-830. PubMed ID: 30534859 [TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. Kelly CR; de Leon L; Jasutkar N J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239 [TBL] [Abstract][Full Text] [Related]
14. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119 [TBL] [Abstract][Full Text] [Related]
15. Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges. Kassam Z; Lee CH; Hunt RH Clin Lab Med; 2014 Dec; 34(4):787-98. PubMed ID: 25439277 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series. Bamba S; Nishida A; Imaeda H; Inatomi O; Sasaki M; Sugimoto M; Andoh A J Microbiol Immunol Infect; 2019 Aug; 52(4):663-666. PubMed ID: 29158082 [TBL] [Abstract][Full Text] [Related]
17. [Fecal microbiota transplantation, a novel therapy for recurrent Clostridium difficile infection]. Terveer EM; van Beurden YH; Kuijper EJ; Keller JJ Ned Tijdschr Tandheelkd; 2016 Sep; 123(9):406-9. PubMed ID: 27643493 [TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622 [TBL] [Abstract][Full Text] [Related]